PONATINIB\PONATINIB: 113 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
113
Total FAERS Reports
37 (32.7%)
Deaths Reported
26
Hospitalizations
113
As Primary/Secondary Suspect
4
Life-Threatening
3
Disabilities
Active Ingredient: PONATINIB\PONATINIB HYDROCHLORIDE ·
First Report: 20160101 · Latest Report: 20240930
What Are the Most Common PONATINIB\PONATINIB Side Effects?
#1 Most Reported
Death
21 reports (18.6%)
#2 Most Reported
Acute lymphocytic leukaemia recurrent
7 reports (6.2%)
#3 Most Reported
Cytopenia
5 reports (4.4%)
All PONATINIB\PONATINIB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 21 | 18.6% | 21 | 1 |
| Acute lymphocytic leukaemia recurrent | 7 | 6.2% | 0 | 0 |
| Chronic myeloid leukaemia | 5 | 4.4% | 2 | 1 |
| Cytopenia | 5 | 4.4% | 0 | 0 |
Who Reports PONATINIB\PONATINIB Side Effects? Age & Gender Data
Gender: 37.4% female, 62.6% male. Average age: 55.4 years. Most reports from: JP. View detailed demographics →
Is PONATINIB\PONATINIB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2016 | 1 | 1 | 0 |
| 2020 | 3 | 0 | 2 |
| 2023 | 14 | 6 | 4 |
| 2024 | 28 | 8 | 16 |
What Is PONATINIB\PONATINIB Used For?
| Indication | Reports |
|---|---|
| Chronic myeloid leukaemia | 50 |
| Philadelphia positive acute lymphocytic leukaemia | 22 |
| Product used for unknown indication | 19 |
| Acute lymphocytic leukaemia | 10 |
PONATINIB\PONATINIB vs Alternatives: Which Is Safer?
PONATINIB\PONATINIB vs PONESIMOD
PONATINIB\PONATINIB vs PORACTANT ALFA
PONATINIB\PONATINIB vs PORFIMER
PONATINIB\PONATINIB vs POSACONAZOLE
PONATINIB\PONATINIB vs POTASSIUM
PONATINIB\PONATINIB vs POTASSIUM, DIBASIC
PONATINIB\PONATINIB vs POTASSIUM IODIDE
PONATINIB\PONATINIB vs POTASSIUM, MONOBASIC
PONATINIB\PONATINIB vs POTASSIUM\SODIUM FLUORIDE
PONATINIB\PONATINIB vs POVIDONE-IODINE
Official FDA Label for PONATINIB\PONATINIB
Official prescribing information from the FDA-approved drug label.